Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The GEN-ERA toolbox: unified and reproducible workflows for research in microbial genomics.
Cornet L, Durieu B, Baert F, D'hooge E, Colignon D, Meunier L, Lupo V, Cleenwerck I, Daniel HM, Rigouts L, Sirjacobs D, Declerck S, Vandamme P, Wilmotte A, Baurain D, Becker P. Cornet L, et al. Among authors: baert f. Gigascience. 2022 Dec 28;12:giad022. doi: 10.1093/gigascience/giad022. Epub 2023 Apr 10. Gigascience. 2022. PMID: 37036103 Free PMC article.
Remarkable fungal biodiversity on northern Belgium bats and hibernacula.
Becker P, van den Eynde C, Baert F, D'hooge E, De Pauw R, Normand AC, Piarroux R, Stubbe D. Becker P, et al. Among authors: baert f. Mycologia. 2023 Jul-Aug;115(4):484-498. doi: 10.1080/00275514.2023.2213138. Epub 2023 Jun 8. Mycologia. 2023. PMID: 37289484
Change in fatigue in patients with ulcerative colitis or Crohn's disease initiating biologic therapy.
Louis E, Bossuyt P, Colard A, Nakad A, Baert D, Mana F, Caenepeel P, Branden SV, Vermeire S, D'Heygere F, Strubbe B, Cremer A, Setakhr V, Baert F, Vijverman A, Coenegrachts JL, Flamme F, Hantson A, Zhou J, Van Gassen G. Louis E, et al. Among authors: baert f. Dig Liver Dis. 2025 Jan 8:S1590-8658(24)01130-7. doi: 10.1016/j.dld.2024.12.011. Online ahead of print. Dig Liver Dis. 2025. PMID: 39788858
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2025 Jan 4;405(10472):33-49. doi: 10.1016/S0140-6736(24)01927-5. Epub 2024 Dec 17. Lancet. 2025. PMID: 39706209 Clinical Trial.
External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab.
Pierre N, Huynh-Thu VA, Baiwir D, Mazzucchelli G, Fléron M, Trzpiot L, Eppe G, De Pauw E, Laharie D, Satsangi J, Bossuyt P, Vuitton L, Vieujean S, Colombel JF, Meuwis MA, Louis E; GETAID and the SPARE-Biocycle research group. Pierre N, et al. Gut. 2024 Nov 11;73(12):1965-1973. doi: 10.1136/gutjnl-2024-332648. Gut. 2024. PMID: 39134391 Free article. Clinical Trial.
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, Peyrin-Biroulet L, D'Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY, Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L, Duan WR, Pivorunas V, Sanchez Gonzalez Y, D'Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M, Loftus EV Jr; INSPIRE and COMMAND Study Group. Louis E, et al. JAMA. 2024 Sep 17;332(11):881-897. doi: 10.1001/jama.2024.12414. JAMA. 2024. PMID: 39037800 Clinical Trial.
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
190 results